NRx Pharmaceuticals, Inc.NRXPNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-10.64M
↑ 25% above average
Average (7y)
$-14.18M
Historical baseline
Range
High:$-135807.00
Low:$-39.77M
CAGR
+86.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-10.64M | +50.9% |
| 2023 | $-21.66M | +45.5% |
| 2022 | $-39.77M | -5.4% |
| 2021 | $-37.71M | -1563.4% |
| 2020 | $-2.27M | -186.0% |
| 2019 | $-792730.00 | -67.5% |
| 2018 | $-473187.00 | -248.4% |
| 2017 | $-135807.00 | - |